Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.95 USD | -0.49% |
|
-1.01% | +12.87% |
30/06 | Xylem Inc.(NYSE:XYL) dropped from Russell 1000 Dynamic Index | CI |
27/06 | Deutsche Bank Adjusts Price Target on Xylem to $152 From $133, Maintains Buy Rating | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.73 | 4.27 | 4.97 | 4.43 | 4.3 | |||||
Return on Total Capital | 5.17 | 5.91 | 6.9 | 5.72 | 5.34 | |||||
Return On Equity % | 8.55 | 13.77 | 10.55 | 8.9 | 8.45 | |||||
Return on Common Equity | 8.57 | 13.81 | 10.58 | 8.92 | 8.55 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 37.65 | 38.09 | 37.81 | 36.9 | 37.51 | |||||
SG&A Margin | 23.75 | 22.96 | 22.4 | 22.18 | 21.74 | |||||
EBITDA Margin % | 15.22 | 15.92 | 15.95 | 17.49 | 19.66 | |||||
EBITA Margin % | 12.82 | 13.65 | 13.94 | 14.87 | 16.64 | |||||
EBIT Margin % | 10.07 | 11.2 | 11.68 | 11.57 | 13.09 | |||||
Income From Continuing Operations Margin % | 5.21 | 8.22 | 6.43 | 8.27 | 10.39 | |||||
Net Income Margin % | 5.21 | 8.22 | 6.43 | 8.27 | 10.39 | |||||
Net Avail. For Common Margin % | 5.21 | 8.22 | 6.43 | 8.27 | 10.39 | |||||
Normalized Net Income Margin | 5.43 | 6.26 | 6.93 | 7.11 | 7.98 | |||||
Levered Free Cash Flow Margin | 11.48 | 4.86 | 6.86 | 6.68 | 11.26 | |||||
Unlevered Free Cash Flow Margin | 12.47 | 5.77 | 7.43 | 7.1 | 11.58 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.59 | 0.61 | 0.68 | 0.61 | 0.53 | |||||
Fixed Assets Turnover | 5.33 | 5.54 | 5.85 | 5.79 | 5.42 | |||||
Receivables Turnover (Average Receivables) | 4.98 | 5.54 | 5.39 | 5.42 | 5.21 | |||||
Inventory Turnover (Average Inventory) | 5.54 | 5.11 | 4.58 | 5.12 | 5.31 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.8 | 2.27 | 1.89 | 1.76 | 1.75 | |||||
Quick Ratio | 1.43 | 1.65 | 1.28 | 1.2 | 1.19 | |||||
Operating Cash Flow to Current Liabilities | 0.42 | 0.39 | 0.37 | 0.38 | 0.54 | |||||
Days Sales Outstanding (Average Receivables) | 73.52 | 65.9 | 67.72 | 67.36 | 70.21 | |||||
Days Outstanding Inventory (Average Inventory) | 66.04 | 71.39 | 79.66 | 71.36 | 68.89 | |||||
Average Days Payable Outstanding | 69.75 | 65.65 | 70.36 | 63.42 | 67.8 | |||||
Cash Conversion Cycle (Average Days) | 69.8 | 71.64 | 77.03 | 75.3 | 71.3 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 113 | 85.31 | 62.75 | 26.79 | 22.45 | |||||
Total Debt / Total Capital | 53.05 | 46.04 | 38.55 | 21.13 | 18.33 | |||||
LT Debt/Equity | 90.73 | 83.17 | 60.78 | 25.59 | 21.1 | |||||
Long-Term Debt / Total Capital | 42.59 | 44.88 | 37.34 | 20.18 | 17.23 | |||||
Total Liabilities / Total Assets | 65.99 | 61.02 | 55.95 | 36.84 | 34.02 | |||||
EBIT / Interest Expense | 6.38 | 7.66 | 12.9 | 17.39 | 25.48 | |||||
EBITDA / Interest Expense | 10.95 | 12.32 | 19.74 | 28.8 | 41.41 | |||||
(EBITDA - Capex) / Interest Expense | 8.57 | 9.58 | 15.58 | 23.27 | 34.11 | |||||
Total Debt / EBITDA | 3.99 | 2.94 | 2.23 | 1.93 | 1.34 | |||||
Net Debt / EBITDA | 1.77 | 1.5 | 1.27 | 1.21 | 0.73 | |||||
Total Debt / (EBITDA - Capex) | 5.1 | 3.78 | 2.82 | 2.39 | 1.63 | |||||
Net Debt / (EBITDA - Capex) | 2.25 | 1.93 | 1.61 | 1.5 | 0.88 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -7.11 | 6.54 | 6.29 | 33.36 | 16.27 | |||||
Gross Profit, 1 Yr. Growth % | -10.48 | 7.79 | 5.51 | 30.37 | 18.22 | |||||
EBITDA, 1 Yr. Growth % | -22.06 | 11.46 | 6.53 | 46.36 | 29.66 | |||||
EBITA, 1 Yr. Growth % | -25.15 | 13.44 | 8.6 | 42.95 | 28.96 | |||||
EBIT, 1 Yr. Growth % | -29.35 | 18.53 | 10.82 | 32.92 | 30.05 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -36.66 | 68.11 | -16.86 | 71.55 | 46.14 | |||||
Net Income, 1 Yr. Growth % | -36.66 | 68.11 | -16.86 | 71.55 | 46.14 | |||||
Normalized Net Income, 1 Yr. Growth % | -32.81 | 22.64 | 17.69 | 37.83 | 29.2 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -36.65 | 67.86 | -16.6 | 42.35 | 30.82 | |||||
Accounts Receivable, 1 Yr. Growth % | -10.91 | 3.25 | 15.01 | 47.99 | 3.15 | |||||
Inventory, 1 Yr. Growth % | 3.52 | 25.45 | 14.14 | 27.41 | -2.16 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.34 | 2.05 | -0.84 | 70.43 | -2.75 | |||||
Total Assets, 1 Yr. Growth % | 13.49 | -5.42 | -3.92 | 102.62 | 2.36 | |||||
Tangible Book Value, 1 Yr. Growth % | -7.29 | -39.73 | -73.73 | -132.26 | 466 | |||||
Common Equity, 1 Yr. Growth % | 0.37 | 8.42 | 8.58 | 190.96 | 4.68 | |||||
Cash From Operations, 1 Yr. Growth % | -1.79 | -34.71 | 10.78 | 40.44 | 50.9 | |||||
Capital Expenditures, 1 Yr. Growth % | -19.03 | 13.66 | 0 | 30.29 | 18.45 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 0.58 | -54.94 | 50.2 | 29.65 | 93.55 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 1.59 | -50.69 | 36.82 | 27.24 | 87.54 | |||||
Dividend Per Share, 1 Yr. Growth % | 8.33 | 7.69 | 7.14 | 10 | 9.09 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -3.23 | -0.52 | 6.42 | 19.06 | 24.52 | |||||
Gross Profit, 2 Yr. CAGR % | -4.8 | -1.65 | 6.82 | 17.29 | 24.15 | |||||
EBITDA, 2 Yr. CAGR % | -11.53 | -6.55 | 9.41 | 25.02 | 37.51 | |||||
EBITA, 2 Yr. CAGR % | -13.28 | -7.58 | 11.53 | 24.63 | 35.51 | |||||
EBIT, 2 Yr. CAGR % | -15.46 | -8.16 | 15.32 | 21.41 | 31.22 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -31.98 | 3.19 | 18.22 | 19.42 | 58.34 | |||||
Net Income, 2 Yr. CAGR % | -31.98 | 3.19 | 18.22 | 19.42 | 58.34 | |||||
Normalized Net Income, 2 Yr. CAGR % | -16.7 | -8.86 | 21 | 27.44 | 34.08 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -32.03 | 3.12 | 18.32 | 8.96 | 36.46 | |||||
Accounts Receivable, 2 Yr. CAGR % | -5.38 | -4.09 | 8.97 | 30.46 | 23.37 | |||||
Inventory, 2 Yr. CAGR % | -3.16 | 13.96 | 19.66 | 20.59 | 11.65 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 19 | 2.69 | 0.59 | 30 | 28.74 | |||||
Total Assets, 2 Yr. CAGR % | 10.07 | 3.61 | -4.67 | 39.53 | 44.02 | |||||
Tangible Book Value, 2 Yr. CAGR % | -17.55 | -25.25 | -60.21 | -70.89 | 35.12 | |||||
Common Equity, 2 Yr. CAGR % | 3.55 | 4.32 | 8.5 | 77.74 | 74.52 | |||||
Cash From Operations, 2 Yr. CAGR % | 18.58 | -19.92 | -14.95 | 24.73 | 45.57 | |||||
Capital Expenditures, 2 Yr. CAGR % | -12.13 | -4.06 | 6.61 | 14.14 | 24.23 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 31.62 | -32.48 | -17.45 | 40.06 | 58.12 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 27.42 | -29.04 | -17.61 | 32.36 | 54.23 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.27 | 8.01 | 7.42 | 8.56 | 9.54 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.18 | -0.08 | 1.7 | 14.73 | 18.12 | |||||
Gross Profit, 3 Yr. CAGR % | -0.2 | -0.78 | 0.68 | 14.08 | 17.6 | |||||
EBITDA, 3 Yr. CAGR % | -3.04 | -4.45 | -2.38 | 20.51 | 26.88 | |||||
EBITA, 3 Yr. CAGR % | -3.94 | -5.15 | -2.47 | 20.94 | 26.44 | |||||
EBIT, 3 Yr. CAGR % | -5.4 | -5.38 | -2.22 | 20.66 | 24.71 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -8.36 | -8.04 | -3.98 | 33.84 | 27.74 | |||||
Net Income, 3 Yr. CAGR % | -8.45 | -8.04 | -3.98 | 33.84 | 27.74 | |||||
Normalized Net Income, 3 Yr. CAGR % | -5.51 | -5.23 | -0.75 | 26.09 | 28.43 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -8.54 | -8.12 | -3.92 | 25.84 | 15.81 | |||||
Accounts Receivable, 3 Yr. CAGR % | -1.16 | -2.59 | 1.89 | 20.67 | 20.51 | |||||
Inventory, 3 Yr. CAGR % | 2.12 | 5.57 | 14.02 | 22.19 | 12.47 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 13.05 | 13.06 | 1.5 | 19.92 | 18.01 | |||||
Total Assets, 3 Yr. CAGR % | 8.45 | 4.65 | 1.04 | 22.57 | 25.84 | |||||
Tangible Book Value, 3 Yr. CAGR % | -11.93 | -25.73 | -47.25 | -62.9 | -21.72 | |||||
Common Equity, 3 Yr. CAGR % | 5.84 | 5.15 | 5.72 | 50.74 | 48.99 | |||||
Cash From Operations, 3 Yr. CAGR % | 6.3 | -2.81 | -10.77 | 0.52 | 32.9 | |||||
Capital Expenditures, 3 Yr. CAGR % | 2.49 | -4.26 | -2.73 | 13.98 | 15.56 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 12.58 | -7.92 | -11.86 | -4 | 56.66 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 11.08 | -7.14 | -11.68 | -4.72 | 49.25 | |||||
Dividend Per Share, 3 Yr. CAGR % | 13.04 | 10.06 | 7.72 | 8.27 | 8.74 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.95 | 6.62 | 3.25 | 7.18 | 10.28 | |||||
Gross Profit, 5 Yr. CAGR % | 5.51 | 5.83 | 2.48 | 6.04 | 9.44 | |||||
EBITDA, 5 Yr. CAGR % | 4.76 | 5.36 | 1.59 | 6.32 | 12.19 | |||||
EBITA, 5 Yr. CAGR % | 4.56 | 5.21 | 1.78 | 5.67 | 11.42 | |||||
EBIT, 5 Yr. CAGR % | 1.53 | 3.67 | 2.15 | 4.4 | 10.19 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -5.67 | 10.43 | 1.47 | 2.1 | 17.29 | |||||
Net Income, 5 Yr. CAGR % | -5.67 | 10.43 | 1.41 | 2.1 | 17.29 | |||||
Normalized Net Income, 5 Yr. CAGR % | 1.17 | 4.46 | 4.02 | 6.52 | 11.79 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -5.62 | 10.14 | 1.38 | -1.64 | 10.56 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.27 | 2.48 | 2.77 | 9.49 | 9.99 | |||||
Inventory, 5 Yr. CAGR % | 5.2 | 6.04 | 8.8 | 11.34 | 13.07 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 16.17 | 9 | 7.89 | 19.55 | 11.62 | |||||
Total Assets, 5 Yr. CAGR % | 13.44 | 5.03 | 3 | 17.41 | 16.43 | |||||
Tangible Book Value, 5 Yr. CAGR % | 72.02 | -18.52 | -35.91 | -48.94 | -23.15 | |||||
Common Equity, 5 Yr. CAGR % | 7.33 | 8 | 6.9 | 29.72 | 29.19 | |||||
Cash From Operations, 5 Yr. CAGR % | 12.17 | 1.6 | -2.77 | 7.39 | 8.52 | |||||
Capital Expenditures, 5 Yr. CAGR % | 9.36 | 10.9 | 4.12 | 2.72 | 7.27 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 14.21 | -5.35 | -0.69 | 8.77 | 11.74 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 13.52 | -4.42 | -1.55 | 6.89 | 10.75 | |||||
Dividend Per Share, 5 Yr. CAGR % | 13.05 | 12.57 | 10.76 | 9.46 | 8.45 |
- Stock Market
- Equities
- XYL Stock
- Financials Xylem Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition